|
| Chemobrain - the term used to describe the congnitive changes some people experience after chemotherapy - has only recently entered into the lime light for people with cancer. But these symptoms that range from difficulty finding the car keys, to an inability to multitask and more, can cause considerable irritation for those who are experiencing chemobrain as well as their loved ones. Best wishes until next week, Dr. Lynne |
| What is Chemobrain?
On a flight this past week I sat next to a man who shared the great difficulties his wife has had with chemobrain. What is "chemobrain" and what are some things you can try to reduce your symptoms? Read more | Blood Clots During Lung Cancer Treatment
Blood clots affect 3 to 15% of people during lung cancer treatment. Do you know how you may prevent them, or at least recognize them when they occur? Read more | Peripheral Neuropathy from Lung Cancer Treatment
Peripheral neuropathy from chemotherapy is not only annoying, it can be dangerous (it's easy to trip when you can't feel your feet) and cause severe pain for some people. What is peripheral neuropathy and what is being researched in clinical trials to prevent this complication? Read more | Depression and Lung Cancer
Depression affects 15 to 25% of cancer patients overall, and an even greater percent of people with lung cancer. But how can you differentiate normal grieving and clinical depression? Read more | |
| | Related Searches | | | | Featured Articles |
| | | | | Sign up for more free newsletters on your favorite topics |
| | | You are receiving this newsletter because you subscribed to the About.com Lung Cancer newsletter. If you wish to change your email address, please click here. If you would like to unsubscribe from all newsletters sent from About.com, please send an email to optout@about.com with "Unsubscribe" as the subject line.
About.com respects your privacy: Our Privacy Policy
Contact Information: 1500 Broadway, 6th Floor New York, NY, 10036
© 2014 About.com | | | |
Must Reads | | | Follow me on: | | | | Advertisement | |
No comments:
Post a Comment